Berliner Boersenzeitung - Jiahui Health develops international CAR-T treatment platform in China

EUR -
AED 3.980447
AFN 76.425222
ALL 100.74696
AMD 436.912951
ANG 1.954503
AOA 898.30222
ARS 392.937771
AUD 1.63805
AWG 1.950986
AZN 1.830865
BAM 1.951392
BBD 2.189653
BDT 119.291604
BGN 1.956511
BHD 0.408517
BIF 3089.061865
BMD 1.083881
BND 1.447842
BOB 7.493072
BRL 5.35958
BSD 1.08445
BTN 90.420727
BWP 14.694735
BYN 3.572763
BYR 21244.074583
BZD 2.185952
CAD 1.467548
CDF 2893.963137
CHF 0.945568
CLF 0.034096
CLP 940.808739
CNY 7.734791
COP 4357.744993
CRC 573.90347
CUC 1.083881
CUP 28.722856
CVE 110.826602
CZK 24.417627
DJF 192.627202
DKK 7.455584
DOP 61.557616
DZD 146.104707
EGP 33.515666
ERN 16.25822
ETB 60.374282
FJD 2.417869
FKP 0.85335
GBP 0.85786
GEL 2.92428
GGP 0.85335
GHS 13.017525
GIP 0.85335
GMD 73.026481
GNF 9326.799239
GTQ 8.494887
GYD 227.067023
HKD 8.471671
HNL 26.770562
HRK 7.632226
HTG 143.435958
HUF 380.062499
IDR 16783.360861
ILS 4.036401
IMP 0.85335
INR 90.413427
IQD 1419.884577
IRR 45807.532299
ISK 150.897687
JEP 0.85335
JMD 168.251448
JOD 0.768909
JPY 159.598269
KES 166.104771
KGS 96.78645
KHR 4462.339992
KMF 490.401878
KPW 975.493515
KRW 1421.153046
KWD 0.334865
KYD 0.903754
KZT 501.148586
LAK 22436.343756
LBP 16370.728438
LKR 355.899971
LRD 203.932469
LSL 20.170719
LTL 3.20042
LVL 0.655629
LYD 5.221253
MAD 10.92606
MDL 19.232551
MGA 4877.466372
MKD 61.637824
MMK 2277.344646
MNT 3720.175292
MOP 8.730676
MRO 386.945458
MUR 47.940177
MVR 16.648524
MWK 1825.799041
MXN 18.932167
MYR 5.051374
MZN 68.555442
NAD 20.171174
NGN 866.021711
NIO 39.848861
NOK 11.747209
NPR 144.673163
NZD 1.758159
OMR 0.417281
PAB 1.084445
PEN 4.050886
PGK 4.047103
PHP 59.990126
PKR 308.635039
PLN 4.329727
PYG 8045.897394
QAR 3.946141
RON 4.968535
RSD 117.329505
RUB 99.166197
RWF 1349.34541
SAR 4.065874
SBD 9.18692
SCR 14.326736
SDG 651.412944
SEK 11.299842
SGD 1.449853
SHP 1.318813
SLE 24.642059
SLL 21406.656447
SOS 619.442693
SRD 40.752891
STD 22434.155727
SYP 14092.607289
SZL 20.171012
THB 38.192721
TJS 11.84758
TMT 3.793585
TND 3.374176
TOP 2.555904
TRY 31.346388
TTD 7.35239
TWD 34.042565
TZS 2715.121734
UAH 39.655031
UGX 4115.702038
USD 1.083881
UYU 42.444503
UZS 13337.16012
VEF 3851696.775976
VES 38.51697
VND 26289.542296
VUV 128.697593
WST 2.90817
XAF 654.475427
XAG 0.044198
XAU 0.000533
XCD 2.929244
XDR 0.813969
XOF 651.412677
XPF 119.064483
YER 271.349422
ZAR 20.378705
ZMK 9756.23296
ZMW 25.836631
ZWL 349.009354
  • NGG

    -0.6300

    66.21

    -0.95%

  • BCC

    2.1800

    114.57

    +1.9%

  • RELX

    0.0300

    38.59

    +0.08%

  • SCS

    -0.0200

    12.44

    -0.16%

  • RBGPF

    0.0260

    68.036

    +0.04%

  • BCE

    0.2900

    40.6

    +0.71%

  • GSK

    0.0600

    36.63

    +0.16%

  • RIO

    -2.1100

    69.05

    -3.06%

  • AZN

    0.2300

    65.02

    +0.35%

  • SCU

    -0.0300

    12.72

    -0.24%

  • CMSC

    -0.1300

    24.48

    -0.53%

  • RYCEF

    0.1060

    3.636

    +2.92%

  • SLAC

    -0.0700

    10.27

    -0.68%

  • CMSD

    -0.2800

    24.05

    -1.16%

  • JRI

    0.0400

    11.32

    +0.35%

  • VOD

    -0.1800

    9.04

    -1.99%

  • BP

    -0.3900

    35.59

    -1.1%

  • BTI

    -0.1100

    31.93

    -0.34%

Jiahui Health develops international CAR-T treatment platform in China
Jiahui Health develops international CAR-T treatment platform in China

Jiahui Health develops international CAR-T treatment platform in China

SHANGHAI, China, Nov. 16, 2023 /PRNewswire/ -- On 10 November 2023, the sixth China International Import Expo (CIIE) successfully concluded at the National Exhibition and Convention Center in Shanghai. This year, Jiahui provided healthcare support for the China International Import Expo (CIIE) as the designated medical provider for the sixth consecutive year. Over and above this, Jiahui Health also participated in the Expo as part of the trade delegation and established in-depth strategic collaborations with several global leading medical brands, one of the most notable of which is IASO Biotechnology.

Text size:

Jiahui Health and IASO BioTherapeutics announced the strategic collaboration to jointly build a BCMA-targeted CAR-T Equecabtagene Autoleucel Injection treatment center.

Jiahui Health and IASO Biotechnology announced a deepening of their strategic collaboration to jointly build a BCMA-targeted CAR-T Equecabtagene Autoleucel Injection treatment center and further promote the long-term sustainable development of the CAR-T international treatment platform. Jiahui will continue to focus on internationally advanced treatment concepts, medication, and technologies for the benefit of local and foreign patients in China.

Jiahui International Cancer Center has established an international CAR-T treatment team and has successfully carried out treatments in collaboration with various companies, including IASO Biotechnology and Fosun Kite. Jiahui's CAR-T multidisciplinary treatment team, led by Dr. Vicky LEE, Director of the Jiahui International Cancer Center and Chief of Medical Oncology at Jiahui International Cancer Center, has conducted a series of studies in the clinical practice of novel technologies and has successfully developed various international treatments.

In September, the first foreign lymphoma patient in China was treated with Akilenza Injection CAR-T and was successfully discharged from Jiahui International Hospital three weeks after completing the infusion. In addition to the CAR-T patients who have been successfully discharged from the hospital after treatment, there are also a number of hematology-oncology patients from abroad who have chosen to undergo CAR-T treatment at Jiahui International Cancer Center. This includes both foreigners who have been living in China for an extended period as well as myeloma patients currently living abroad who are in urgent need of CAR-T treatment. Jiahui has been their choice for treatment based on the international standard hardware and software available, the comprehensive treatment capabilities, the cross-cultural and multilingual setting, the comfortable environment, and the international standard cost-effective clinical application of CAR-T therapy provided.

Jiahui International Cancer Center (JICC), affiliated with Shanghai Jiahui International Hospital in Shanghai, China, has a close strategic collaboration with Massachusetts General Hospital (MGH) and its cancer center. Jiahui International Cancer Center represents the cutting edge of international oncology, by integrating both internal and external medical and social resources to provide comprehensive diagnosis and treatment, fully aligned with the concept of holistic care.

(Y.Berger--BBZ)